References
- Issels RD, Lindner LH, Wust P, Hohenberger P, Jauch K, Daugaard S, Mansmann U, Hiddemann W, Blay J, Verweij J. Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen. A phase III randomised prospective trial (EORTC/ESHO intergroup trial), JCO 2007 ASCO Annual Meeting Proceedings Part I 2007;25(Suppl. 18):10009
- Van der Zee J, van Rhoon GC. Cervical cancer: Radiotherapy and hyperthermia. Int J Hyperthermia 2006; 22: 229–234, Review
- Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
- Rau B, Wust P, Hohenberger P, Loeffel J, Huenerbein M, Below C, Gellermann J, Speidel A, Vogl T, Riess H, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial. Ann Surg 1998; 227: 380–389
- Hildebrandt B, Wust P, Rau B, Schlag PM, Riess H. Regional hyperthermia for rectal cancer. Lancet 2000; 356: 771–772
- Hildebrandt B, Wust P, Drager J, Luedemann L, Sreenivasa G, Tullius SG, Amtauer H, Neuhaus P, Felix R, Riess H. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: A pilot study. Int J Hyperthermia 2004; 20: 359–369
- Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345(8949)540–543
- Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
- Gellermann J, Wlodarczyk W, Hildebrandt B, Ganter H, Nicolau A, Rau B, Tilly W, Faehling H, Nadobny J, Felix R, et al. Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 2005; 65: 5872–5880
- Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V, Felix R, Tunn PU, Reichardt P, Wust P. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: Correlation with response and direct thermometry. Cancer 2006; 107: 1373–1382
- Wust P, Gellermann J, Seebass M, Faehling H, Turner P, Wlodarczyk W, Nadobny J, Rau B, Hildebrandt B, Oppelt A, et al. [Part-body hyperthermia with a radiofrequency multiantenna applicator under online control in a 1.5 T MR-tomograph.]. Rofo 2004; 176: 363–374
- Gellermann J, Wlodarczyk W, Feussner A, Faehling H, Nadobny J, Hildebrandt B, Felix R, Wust P. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia 2005; 21: 497–513
- Wust P, Beck R, Berger J, Faehling H, Seebass M, Wlodarczyk W, Hoffmann W, Nadobny J. Electric field distribution in a phased-array applicator with 12 channels: Measurements and numerical simulations. Med Phys 2000; 27: 2565–2579
- Delannoy J, LeBihan D, Hoult DI, Levin RL. Hyperthermia system combined with a magnetic resonance imaging unit. Med Phys Biol 1990; 12: 855–860
- Gellermann J, Goke J, Figiel R, Weihrauch M, Cho CH, Budach V, Felix R, Wust P. Simulation of different applicator positions for treatment of a presacral tumour. Int J Hyperthermia 2007; 23: 37–47
- Mirowitz SA. Liver and biliary system. Pitfalls, variants and artifacts in body MR imaging. Mosby-Year Book, Inc, St. Louis, MO 1996; 101–153
- Weihrauch M, Wust P, Weiser M, Nadobny J, Eisenhardt S, Gellermann J. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in an hybrid MR-HT system. Med Phys 2007; 34: 4717–4725